Book Chapters
Schep L, Poulsen H, Gee P. (2017) “Analytical Advances in Drug Detection of Piperazines” in “Detection of Misused Drugs”. Royal Society of Chemistry, London. ISBN: 9781782621577. Editor Wolff K.
Slaughter R., Temple W., Schep L. (2014): Poisonings and Natural Toxins in New Zealand. In: Gopalakrishnakone P. (Ed.) Handbook of Toxinology. Clinical Toxinology: SpringerReference (www.springerreference.com). Springer-Verlag Berlin Heidelberg. DOI: 10.1007/SpringerReference_353760 2013-07-01 14:52:00 UTC.
Schep L, Slaughter R. (2014): Methylenedioxymethamphetamine. In: "Encyclopedia of Toxicology" - 3rd Edition. Elsevier Inc., Academic Press, pp. 294–296. ISBN: 9780123864543.
Gee P, Schep L (2013): “Benzylpiperazine and other piperazine-based derivatives”. In “Novel Psychoactive Substances: Classification, Pharmacology and Toxicology”. Academic Press. London. Editors: Dargan P and Wood D. ISBN: 978-0-12-415816-0
Now available as second edition ISBN:9780128187883
Schep LJ (2009): “Death of Alexander the Great; reconsidering poisoning”. In “Alexander and His Successors. Essays from the Antipodes”. Regina Books, Claremont, CA. Editors: Wheatley P and Hannah R. ISBN: 1-930053-58-64
Refereed Journal Articles
Schep LJ, Slaughter RJ, Glue P, Gee P. (2020) “The clinical toxicology of cannabis”. The New Zealand Medical Journal. 133 (11523): 96-102.
Slaughter RJ, Watts M, Vale A, Grieve J, Schep LJ. (2019) “The clinical toxicology of sodium hypochlorite”. Clinical Toxicology. 57(5): 303-311.
Slaughter RJ, Beasley DM, Schep LJ. (2017) “Dermatitis due to Toxicodendron plants: a common occurrence during autumn”. New Zealand Medical Journal. 130 (1451): 82-83.
Schep LJ, Slaughter RJ, Galea S, et al. (2016) “Ibogaine for treating drug dependence. What is a safe dose?” Drug and alcohol dependence. 166(1):1-5.
Gee P, Schep LJ, Jensen BP, Moore G, Barrington S. (2016) “Case series: toxicity from 25B-NBOMe - a cluster of N-bomb cases”. Clinical Toxicology. 54 (2): 141-146.
Schep LJ, Slaughter RJ, McBride D. (2015) “Riot control agents: the tear gases CN, CS and OC—a medical review”. Journal of the Royal Army Medical Corps. 161: 94-99.
Schep LJ, Slaughter RJ, Hudson, S, Place R, Watts, M. (2015) “Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues”. Human and Experimental Toxicology. 34(5):557-560.
Schep LJ, Slaughter RJ. (2015) “Availability and quantity of antidotes in New Zealand”. Invited editorial. The New Zealand Medical Journal. 128 (1411): 20-22.
Millard YC, Slaughter RJ, Shieffelbien, LM, Schep LJ,. (2014) “Poisoning following exposure to chemicals stored in mislabeled or unlabeled containers: A recipe for potential disaster”. The New Zealand Medical Journal. 127(1403):17-23.
Schep LJ, Gee P, Tingle M, Galea S, Newcombe D. (2014) “Regulating novel psychoactive drugs: Innovation leading to compromise”. British Medical Journal. 349: g5085.
Schep LJ, Slaughter RJ, Vale JA, Wheatley P. (2014) “Response to letter to the Editor regarding ‘A note on Conium maculatum L., the plant that defeated Alexander the Great’ in Clinical Toxicology”. Clinical Toxicology. 52(6):646.
Slaughter RJ, Mason RW, Beasley MG, Vale JA, Schep LJ. (2014) “Isopropanol poisoning”. Clinical Toxicology. 52(5): 470-478.
Slaughter RJ, Temple WA, Schep LJ. (2014) “Pediatric poisoning due to nicotine replacement therapy products: An emerging hazard”. Journal of Pediatrics and Child Health. 50(2):164-165.
Schep LJ, Slaughter RJ, Vale JA, Wheatley P. (2014) “Was the death of Alexander the Great due to poisoning. Was it Veratrum album”. Clinical Toxicology. 52(1):72-77.
Beasley DMG, Schep LJ, Slaughter RJ, Michel JM. (2014) “Full recovery from a potentially lethal dose of mercuric chloride”. Journal of Medical Toxicology.10(1):40-44.
Glue P, Al-Shaqsi S, Hancock D, Gale C, Strong B, Schep L. (2013) “Hospitalization associated with use of the synthetic cannabinoid K2”. The New Zealand Medical Journal. 126(1377):18-23.
Gresham C, Utting K, Williams C, Schep L. (2013) “Colchicine poisoning: defusing the ticking time bomb”. The New Zealand Medical Journal. 126 (1370): 115-6.
Schep LJ, Slaughter RJ, Temple WA, Lambie BS, Gee P, Watts M, Gresham C. (2012) “Synthetic cannabinoid use in New Zealand. A recent rebound”. The New Zealand Medical Journal. 125 (1364): 114-6.
Slaughter RJ, Beasley DM, Lambie BS, Schep LJ. (2012) “Poisonous plants in New Zealand: The top 10 inquiries on plants received by the New Zealand National Poisons Centre”. New Zealand Medical Journal. 125 (1367): 87-118.
McBride D, Schep LJ. (2012) “Comment on Carran and Shaw's "New Zealand Malayan war veterans’ exposure to dibutylphthalate" article”. New Zealand Medical Journal 125 (1361):105-106. [Letter]
Schep LJ, Knudsen K, Slaughter RJ, Vale JA, Megarbane B. (2012) “The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol”. Clinical Toxicology. 50:458-70.
Schep LJ, Slaughter RJ, Temple WA, Gee P. (2012) “Comments on BZP and New Zealand’s alternative approach to prohibition”. Drug Testing and Analysis. 4(1):57 [Letter]
Schep LJ, Slaughter RJ, Temple WA, (2011) “Synthetic cannabinoid use in New Zealand: a brief evaluation of inquiries to the New Zealand National Poisons Centre”. New Zealand Medical Journal 124 (1347):85-86. [Letter]
Schep LJ, Slaughter RJ, Vale JA, Beasley DMG, Gee P. (2011) “The clinical toxicology of the designer ‘party pills’ benzylpiperazine and trifluoromethylphenylpiperazine”. Clinical Toxicology 49(3):131–141.
Schep LJ, Slaughter RJ, Temple WA, Nair SM, Gee P. (2011) “Synthetic cannabinoid analogues—not repeating past mistakes”. New Zealand Medical Journal 124 (1332):85-86. [Letter]
Schep LJ, Slaughter RJ, Beasley DMG. (2010) “Clinical toxicity of methamphetamine”. Clinical Toxicology 48(7):675–694.
Schep LJ, Slaughter RJ, Temple WA Beasley DMG. (2010) “Ciguatera poisoning: an increasing occurrence in New Zealand”. New Zealand Medical Journal 123 (1308). [Letter]
Schep LJ, Slaughter RJ, Vale A, Beasley DMG. (2009) “A seaman with blindness and confusion”. British Medical Journal. 339:b3929
Schep LJ, Slaughter RJ, Beasley DMG. (2009) “Nicotinic plant poisoning”. Clinical Toxicology. 46(8):771-781. Commissioned review.
Schep LJ, Temple WA, Butt G, Beasley, MD. (2009) “Ricin as a weapon of mass terror – separating fact from fiction”. Environment International. 35(8):1267-1271.
Schep LJ, Slaughter RJ, Beasley DMG, Temple WA. (2009) “Diethylene glycol poisoning”. Clinical Toxicology. 46(6) 525-535. Commissioned review.
Schep LJ, Slaughter RJ, Temple WA. (2009) “Contaminant berries in frozen vegetables”. New Zealand Medical Journal 122 (1292) 95-96. [Letter]
Schep LJ, Slaughter RJ, Becket G, Beasley MD. (2009) “Poisoning due to water hemlock”. Clinical Toxicology. 47(4):270-278. Commissioned review.
Slaughter RJ, Lambie BS, Beasley DMG, Schep LJ. (2009) “New Zealand's venomous creatures”. New Zealand Medical Journal. 122(1290):83-97.
Armstrong, DA. Schep L, (2009). “Comparing bromism with methyl bromide toxicity”. Clinical Toxicology. 47(4):371-372. [Letter]
Schep L, Temple WA, Beasley, MD (2009). “The adverse effects of hydrogen cyanamide on human health: an evaluation of inquiries to the New Zealand National Poisons Centre”. Clinical Toxicology. 47(1):58-60.
Schep LJ, Schmierer DM, Fountain JS. (2006) “Veratrum poisoning”. Toxicological Reviews. 25(2):73-78.
Schep LJ, Fountain JS, Cox WM, Pesola GR. (2006) “Lead Shot Accumulation in the Appendix”. New England Journal of Medicine. 354(16):1757. [Letter]
Schep LJ, Slaughter RJ. (2005) “Comments on diethylene glycol concentrations” Forensic Science International. 155(2-3):233.
Watts M, Fountain JS, Reith D, Schep L. (2004) “Compliance with Poisons Center referral advice and implications for toxicovigilance”. Clinical Toxicology. 42(5):603-10.